Empirical Ground-Motion Prediction Equations for Northern Italy Using Weak- and Strong-Motion Amplitudes, Frequency Content, and Duration Parameters

The goals of this work are to review the Northern-Italy ground-motion prediction equations (GMPEs) for amplitude parameters and to propose new GMPEs for frequency content and duration parameters. Approximately 10,000 weak and strong waveforms have been collected merging information from different neighboring regional seismic networks operating in the last 30 yr throughout Northern Italy. New ground-motion models, calibrated for epicentral distances ≤100 km and for both local (ML) and moment magnitude (Mw), have been developed starting from a high quality dataset (624 waveforms) that consists of 82 selected earthquakes with ML and Mw up to 6.3 and 6.5, respectively. The vertical component and the maximum of the two horizontal components of motion have been considered, for both acceleration (peak ground horizontal acceleration [PGHA] and peak ground vertical acceleration [PGVA]) and velocity (peak ground horizontal velocity [PGHV] and peak ground vertical velocity [PGVV]) data. In order to make comparisons with the most commonly used prediction equations for the Italian territory (Sabetta and Pugliese, 1996 [hereafter, SP96] and Ambraseys et al. 2005a,b [hereafter, AM05]) the coefficients for acceleration response spectra (spectral horizontal acceleration [SHA] and spectral vertical acceleration [SVA]) and for pseudovelocity response spectra (pseudospectral horizontal velocity [PSHV] and pseudospectral vertical velocity [PSVV]) have been calculated for 12 periods ranging between 0.04 and 2 sec and for 14 periods ranging between 0.04 and 4 sec, respectively. Finally, empirical relations for Arias intensities (IA), Housner intensities (IH), and strong motion duration (DV) have also been calibrated. The site classification based on Eurocode (hereafter, EC8) classes has been used (ENV, 1998, 2002). The coefficients of the models have been determined using functional forms with an independent magnitude decay rate and applying the random effects model (Abrahamson and Youngs, 1992; Joyner and Boore, 1993) that allow the determination of the interevent, interstation, and record-to-record components of variance. The goodness of fit between observed and predicted values has been evaluated using the maximum likelihood approach as in Spudich et al. (1999). Comparing the proposed GMPEs with SP96 and AM05, it is possible to observe a faster decay of predicted ground motion, in particular for distances greater than 25 km and magnitudes higher than 5.0. The result is an improvement in fit of about one order of size for magnitudes spanning from 3.5 to 4.5

Empirical ground motion prediction equations for northern italy using weak and strong motion amplitudes, frequency content and duration parameters

The aims of this work are to review the Northern-Italy ground motion prediction equations (hereinafter GMPEs) for amplitude parameters and to propose new GMPEs for frequency content and duration parameters. Approximately 10.000 weak and strong waveforms have been collected merging information from different neighbouring regional seismic networks operating in the last 30 years throughout Northern Italy. New ground motion models, calibrated for epicentral distances ≤ 100 km and for both local (Ml) and moment magnitude (Mw), have been developed starting from a high quality dataset (624 waveforms) which consists of 82 selected earthquakes with Ml and Mw up to 6.3 and 6.5 respectively. The vertical component and the maximum of the two horizontal components of motion have been considered, for both acceleration (PGHA and PGVA) and velocity (PGHV and PGVV) data. In order to make comparisons with the most commonly used prediction equations for the Italian territory (Sabetta and Pugliese, 1996 and Ambraseys et al. 2005a,b hereinafter named SP96 and AM05) the coefficients for acceleration response spectra (SHA and SVA) and for pseudo velocity response spectra (PSHV and PSVV) have been calculated for 12 periods ranging between 0.04 s and 2 s and for 14 periods ranging between 0.04 s and 4 s respectively. Finally, empirical relations for Arias and Housner Intensities (IA, IH) and strong motion duration (DV) have also been calibrated. The site classification based on Eurocode (hereinafter EC8) classes has been used (ENV, 1998). The coefficients of the models have been determined using functional forms with an independent magnitude decay rate and applying the random effects model (Abrahamson and Youngs, 1992; Joyner and Boore, 1993) that allow the determination of the inter-event, inter-station and record-to-record components of variance. The goodness of fit between observed and predicted values has been evaluated using the maximum likelihood approach as in Spudich et al. (1999). Comparing the proposed GMPEs both with SP96 and AM05 it is possible to observe a faster decay of predicted ground motion, in particular for distances greater than 25 km and magnitudes higher than 5.0. The result is a fit improvement of about one order of size for magnitudes spanning from 3.5 to 4.5

Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene.

Abstract Using a Sendai Virus based vector delivering Yamanaka Factors, we generated induced Pluripotent Stem Cells (iPSCs) from peripheral blood mononuclear cells of a patient affected by Ataxia Telangiectasia (AT), caused by a novel homozygous deletion in ATM, spanning exons 5 to 7. Three clones were fully characterized for pluripotency and capability to differentiate. These clones preserved the causative mutation of parental cells and genomic stability over time (>100 passages). Furthermore, in AT derived iPSCs we confirmed the impaired DNA damage response after ionizing radiation. All these data underline potential usefulness of our clones as in vitro AT disease model

Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects

Hermansky Pudlak type 2 syndrome (HPS2) is a rare autosomal recessive primary immune deficiency caused by mutations on b3A gene (AP3B1 gene). The defect results in the impairment of the adaptor protein 3 (AP-3) complex, responsible for protein sorting to secretory lysosomes leading to oculo-cutaneous albinism, bleeding disorders and immunodeficiency. We have studied peripheral blood and lymph node biopsies from two siblings affected by HPS2. Lymph node histology showed a nodular lymphocyte predominance type Hodgkin lymphoma (NLPHL) in both HPS2 siblings. By immunohistochemistry, CD8 T-cells from HPS2 NLPHL contained an increased amount of perforin (Prf) + suggesting a defect in the release of this granules-associated protein. By analyzing peripheral blood immune cells we found a significant reduction of circulating NKT cells and of CD56brightCD162 Natural Killer (NK) cells subset. Functionally, NK cells were defective in their cytotoxic activity against tumor cell lines including Hodgkin Lymphoma as well as in IFN-c production. This defect was associated with increased baseline level of CD107a and CD63 at the surface level of unstimulated and IL-2-activated NK cells. In summary, these results suggest that a combined and profound defect of innate and adaptive effector cells might explain the susceptibility to infections and lymphoma in these HPS2 patients.peer-reviewe

A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP

A female offspring of consanguineous parents, showed features of Wiskott-Aldrich syndrome (WAS), including recurrent infections, eczema, thrombocytopenia, defective T cell proliferation and chemotaxis, and impaired natural killer cell function. Cells from this patient had undetectable WAS protein (WASP), but normal WAS sequence and messenger RNA levels. WASP interacting protein (WIP), which stabilizes WASP, was also undetectable. A homozygous c.1301C>G stop codon mutation was found in the WIPF1 gene, which encodes WIP. Introduction of WIP into the patient’s T cells restored WASP expression. These findings indicate that WIP deficiency should be suspected in patients with features of WAS in whom WAS sequence and mRNA levels are normal

Seismic hazard for the Trans Adriatic Pipeline (TAP). Part 2: broadband scenarios at the Fier Compressor Station (Albania)

AbstractTo ensure environmental and public safety, critical facilities require rigorous seismic hazard analysis to define seismic input for their design. We consider the case of the Trans Adriatic Pipeline (TAP), which is a pipeline that transports natural gas from the Caspian Sea to southern Italy, crossing active faults and areas characterized by high seismicity levels. For this pipeline, we develop a Probabilistic Seismic Hazard Assessment (PSHA) for the broader area, and, for the selected critical sites, we perform deterministic seismic hazard assessment (DSHA), by calculating shaking scenarios that account for the physics of the source, propagation, and site effects. This paper presents a DSHA for a compressor station located at Fier, along the Albanian coastal region. Considering the location of the most hazardous faults in the study site, revealed by the PSHA disaggregation, we model the ground motion for two different scenarios to simulate the worst-case scenario for this compressor station. We compute broadband waveforms for receivers on soft soils by applying specific transfer functions estimated from the available geotechnical data for the Fier area. The simulations reproduce the variability observed in the ground motion recorded in the near-earthquake source. The vertical ground motion is strong for receivers placed above the rupture areas and should not be ignored in seismic designs; furthermore, our vertical simulations reproduce the displacement and the static offset of the ground motion highlighted in recent studies. This observation confirms the importance of the DSHA analysis in defining the expected pipeline damage functions and permanent soil deformations

REVISITING THE APOLLO PHOTOGRAMMETRIC MAPPING SYSTEM

The integrated photogrammetric mapping system flown on the last three Apollo lunar missions (AS15, AS16, and AS17) in 1971 and 1972 incorporated a Metric (mapping) Camera, a high-resolution Panoramic Camera, and a star camera and laser altimeter. The U.S. Geological Survey’s Astrogeology Science Center, the Intelligent Robotics Group of the NASA Ames Research Center, and Arizona State University are working together in an ongoing collaboration to achieve the most complete cartographic development of Apollo mapping system data into versatile digital map products. These will enable a variety of scientific/engineering uses of the data including mission planning, geologic mapping, geophysical process modelling, slope dependent correction of spectral data, and change detection. After a brief discussion of the origins of the mapping system, we describe the Metric and Panoramic cameras, processing of the associated image and support data, work to photogrammetrically control the Metric Camera images, and future plans

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content.

Mutations of the recombinase Activating Genes 1 and 2 (RAG1, RAG2) in humans are associated with a broad range of phenotypes. For patients with severe clinical presentation, hematopoietic stem cell transplantation (HSCT) represents the only curative treatment, however high rates of graft failure and incomplete immune reconstitution have been observed, especially after unconditioned haploidentical transplantation. Studies in mice have shown that Rag-/- NK cells have a mature phenotype, reduced fitness and increased cytotoxicity. We aimed to analyze NK cell phenotype and function in patients with mutations in RAG and in non-homologous end joining (NHEJ) genes. Here we provide evidence that NK cells from these patients have an immature phenotype, with significant expansion of CD56bright CD16-/int CD57- cells, yet increased degranulation and high perforin content. Correlation was observed between in vitro recombinase activity of the mutant proteins, NK cell abnormalities, and in vivo clinical phenotype. Addition of serotherapy in the conditioning regimen, with the aim of depleting the autologous NK cell compartment, may be important to facilitate engraftment and immune reconstitution in patients with RAG and NHEJ defects treated by HSCT

Status Update and Interim Results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2)

Objectives: ACST-2 is currently the largest trial ever conducted to compare carotid artery stenting (CAS) with carotid endarterectomy (CEA) in patients with severe asymptomatic carotid stenosis requiring revascularization. Methods: Patients are entered into ACST-2 when revascularization is felt to be clearly indicated, when CEA and CAS are both possible, but where there is substantial uncertainty as to which is most appropriate. Trial surgeons and interventionalists are expected to use their usual techniques and CE-approved devices. We report baseline characteristics and blinded combined interim results for 30-day mortality and major morbidity for 986 patients in the ongoing trial up to September 2012. Results: A total of 986 patients (687 men, 299 women), mean age 68.7 years (SD ± 8.1) were randomized equally to CEA or CAS. Most (96%) had ipsilateral stenosis of 70-99% (median 80%) with contralateral stenoses of 50-99% in 30% and contralateral occlusion in 8%. Patients were on appropriate medical treatment. For 691 patients undergoing intervention with at least 1-month follow-up and Rankin scoring at 6 months for any stroke, the overall serious cardiovascular event rate of periprocedural (within 30 days) disabling stroke, fatal myocardial infarction, and death at 30 days was 1.0%. Conclusions: Early ACST-2 results suggest contemporary carotid intervention for asymptomatic stenosis has a low risk of serious morbidity and mortality, on par with other recent trials. The trial continues to recruit, to monitor periprocedural events and all types of stroke, aiming to randomize up to 5,000 patients to determine any differential outcomes between interventions. Clinical trial: ISRCTN21144362. © 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved